Algodign, LLC is developing novel software for structure-based drug design, based on advanced methods of physics. The research operations of this U.S. company are primarily conducted in Russia to take advantage of the large pool of highly qualified physicists there. Algodign was created and financed by an established biotechnology executive, who recruited as co-founders an experienced Russian/American executive to run its Russian operations and an eminent American scientist to lead its Scientific Advisory Board. The Company currently employs the talents of about 25 scientists at its Moscow facility.
| Website | http://www.algodign.com |
| Revenue | $3.8 million |
| Employees | View employees |
| Industry | Manufacturing General, Manufacturing |
| SIC | SIC Code 28 Companies, SIC Code 283 Companies |
| NAICS | NAICS Code 325 Companies, NAICS Code 3254 Companies, NAICS Code 32 Companies |
Looking for a particular Algodign employee's phone or email?
Algodign Questions
The Algodign annual revenue was $3.8 million in 2026.
The NAICS codes for Algodign are [325, 3254, 32].
The SIC codes for Algodign are [28, 283].
